Drug maker stopped making popular antibiotic Levaquin amid concerns about mental health side effects (WRTV Indianapolis)
INDIANAPOLIS—The makers of a popular antibiotic have halted production on the drug amid safety concerns.
Janssen pharmaceutical companies of Johnson & Johnson discontinued production of Levaquin in December 2017, including the oral and IV versions.
However, Levaquin may still be available in pharmacies until 2020.
“The decision to discontinue LEVAQUIN was made due to the wide availability of alternative treatment options, and our focus on developing innovative medicines designed to address unmet medical patient needs,” said Kelsey Buckholtz, a spokeswoman for Janssen in an email to RTV6.